Blogs Archives - 24/7 QualityMeds

November 14, 2025

Order-Velaglucerase-Alfa-in-India-Pricing-Supplier-Info-1280x800.png

Velaglucerase alfa is indicated for long-term enzyme replacement therapy (ERT) for patients with type 1 Gaucher disease. Gaucher disease is an autosomal recessive disorder where GBA gene mutation results in deficiency of beta-glucocerebrosidase. This lysosomal enzyme catalyzes conversion of the sphingolipid glucocerebroside into glucose and ceramide. However, in deficiency of this enzyme glucocerebroside can accumulate in the lysosomal compartment of macrophages, giving rise to foam cells or “Gaucher cells”. Velaglucerase alfa catalyzes hydrolysis of this glucocerebroside, reducing its amount.

In clinical trials, this product reduced spleen and liver size, and improved anemia and thrombocytopenia.

The most common adverse reactions include hypersensitivity reactions, headache, dizziness, abdominal pain, nausea, back pain, joint pain, prolonged activated PTT, fatigue/asthenia, and pyrexia. Available data does not establish or exclude the absence of a velaglucerase alfa associated risk during pregnancy or any major birth defects, miscarriage, or any other adverse maternal or fetal outcomes. Sufficient data is not available to determine any effects on the breastfed infant or on milk production. Endogenous beta-glucocerebrosidase is present in human milk. The benefits of breastfeeding should be taken into consideration along with the mother’s clinical need for the medicine and any potential adverse effects on the breastfed child or from the underlying maternal condition.

Safety and effectiveness have been established for enzyme replacement therapy (ERT) in patients in the range of 4-17 years of age with type 1 Gaucher disease. The safety and efficacy profiles were similar between pediatric and adult patients. However, the efficacy and safety of the product has not been established in pediatric patients younger than 4 years of age.

Reported clinical experience has not identified differences in responses between geriatric and younger patients. Dose selection for an elderly patient should be approached cautiously, considering potential comorbid conditions.

Pricing and availability

Velaglucerase alfa is not currently registered in India and is therefore not available through regular pharmacies or standard distribution channels.
As this is a prescription-only medication, a price quotation for obtaining information on price of velaglucerase alfa in India, is shared only after reviewing valid medical documents and a doctor’s prescription. For the most up-to-date pricing and supply details, patients may contact our support team to access and buy velaglucerase alfa in India.

The price of velaglucerase alfa in India may differ based on factors such as market demand, supplier access, import regulations, and availability from international manufacturers. The total cost may also depend on shipping charges, origin country, documentation fees, and currency exchange rates.

Pricing may be affected by local taxes (GST) and any revisions in company or distributor pricing policies.
We assist patients in India with the safe and lawful access to velaglucerase alfa through the Named Patient Supply (NPS) program, ensuring compliance with all import regulations. Our services include document verification, import coordination, and doorstep delivery of the medicine.

Patient Access

Since velaglucerase alfa is not approved for commercial sale in India, it can be obtained only through the Named Patient Import Program (NPIP).
We help patients obtain unregistered medicines like velaglucerase alfa under the NPS route, maintaining full adherence to applicable legal and regulatory standards.

Velaglucerase alfa is available as 400 units/vial, for injection as a sterile, preservative free, white to off-white lyophilized powder requiring reconstitution and dilution before using. It is supplied in individually packaged single-dose glass vials.

Import Procedure

Medicine Request Submission: Patients or caregivers can initiate the process by submitting a request along with the doctor’s prescription and treatment information.
Filing Form 12A: A completed Form 12A, together with a valid prescription from a Registered Medical Practitioner (RMP), must be provided.
Verification Process: All submitted documents are thoroughly reviewed to confirm the patient’s eligibility to import the medicine for personal medical use.
Regulatory Approval: Once approval is granted by the Drugs Controller General (India), the import procedure is carried out in line with the approved prescription.
Medicine Procurement: Our procurement specialists coordinate with licensed international suppliers to source the medicine at the best available rate while ensuring authenticity and quality.
Product Delivery: After approval and shipment, logistics are managed to ensure safe, timely, and compliant delivery of the medicine to the patient’s address in India.

Documents required

To import velaglucerase alfa in India, patients must provide the following:

A valid prescription indicating the medicine name, dosage, duration, and diagnosis.
Recent medical history and diagnostic reports (preferably from the last three months).
Government-issued ID proof and proof of residence.
Import permit (if required).

Orders are confirmed only after the submission and verification of all necessary documents. Once the import authorization is granted, shipment velaglucerase alfa is arranged by a licensed global supplier—typically from the USA, Canada, Europe, or Australia.

This process ensures that patients in India can legally and securely access velaglucerase alfa. We coordinate with reliable international sources, maintain pricing transparency, and ensure all deliveries are pharmacist-verified and fully compliant with import regulations.

Looking for detailed product information or pricing? Our team at 24/7QualityMeds.com is here to help you anytime.

by 24/7QualityMeds

November 13, 2025

Kineret-Anakinra-in-India-Uses-Administration-Where-to-Buy-2-1280x800.jpg

Kineret is a prescription medication used to treat medical conditions like Rheumatoid Arthritis (RA) in adults, Neonatal-Onset Multisystem Inflammatory Disease (NOMID) in newborns, and in cases of decreased Interleukin-1 Receptor Antagonist (Blocks interleukin-1 from activating inflammation in the body).

How does Kineret (Anakinra) work?

Anakinra is the key component in the Kineret, which works as an immunosuppressive agent (that suppresses the immune system in the body). This replicates the interleukin 1 (IL-1) receptor antagonist in humans, which stops the receptors for signal molecules in the body known as interleukin 1. When the signal molecules are produced in higher quantities, it leads to inflammation of joints. By uniting the receptors that IL-1 usually attaches itself to, Anakinra obstructs IL-1 activity, resulting in relieving the symptoms of RA.

Indications

Kineret is indicated in:

1) Rheumatoid Arthritis: Reduction in signs and symptoms and slowing the progression of the structural damage in moderately to severely active Rheumatoid arthritis (RA), in patients 18 years of age or older who have failed 1 or more disease-modifying antirheumatic drugs (DMARDs).

2) Cryopyrin-Associated Periodic Syndromes (episodes of uncontrolled inflammation) Treatment of Neonatal-onset Multisystem Inflammatory Disease (NOMID)

3) Deficiency of Interleukin-1 Receptor Antagonist (Blocks interleukin-1 from activating inflammation in the body)

Side-effects

Rheumatoid Arthritis (RA)

The common side effects are injection site reaction, worsening of Rheumatoid Arthritis, upper respiratory tract infection, headache, nausea, diarrhea, sinusitis, arthralgia (Joint pain), flu-like symptoms, and abdominal pain.

NOMID: During the initial 6 months of treatment, injection site reactions, headache, vomiting, arthralgia, pyrexia (high body temperature), and nasopharyngitis are common side effects.

DIRA: Upper respiratory tract infections, rash, pyrexia (high body temperature), influenza-like illness, and gastroenteritis are common side effects in patients with DIRA.

Dosage and administration

Rheumatoid Arthritis (RA)

The recommended dose of Kineret for patients suffering from RA is 100mg per day, which is to be administered by subcutaneous injection every day. This dosage is maintained around the same time daily.
Physicians should consider a dose of 100mg of Kineret administrated everyday for RA patients who have severe renal insufficiency or end-stage renal disease (defined as a creatinine clearance less than 30mL/min, as estimated from serum creatinine levels).

NOMID

The recommended starting dose of Kineret is 1-2mg/kg everyday for patients suffering from NOMID.
Physicians should consider a dose of 1-2mg/kg of Kineret every other day for NOMID patients who have severe renal insufficiency or end stage renal disease (defined as a creatinine clearance less than 30mL/min, as estimated from serum creatinine levels).

DIRA

The recommended initial dose is 1-2mg/kg daily for patients with DIRA. The dose can be individually adjusted to a maximum of 8mg/kg daily to control active inflammation.
Physicians should consider administration of the Kineret dose every other day for patients with DIRA who have several renal insufficiencies or end-stage renal disease(defined as a creatinine clearance less than 30mL/min, as estimated from serum creatinine levels).

Where to buy Kineret in India?

Since Kineret is not registered in India, it’s not possible to get access in India except through legal means. However, we are here to help you in this process to import anakinra in India safely and on time. The anakinra price in India is completely based on the parameters like its distribution status, supply chain management, transportation, and tariffs, but we can assure you that we offer it at a very competitive price. The packaging comes as a single-use prefilled syringe designed for subcutaneous injections. The dosage of the injection is 100mg/0.67mL solution. We will walk you through this systematic protocol to import anakinra.

1) Placing an order request

You can request by notifying us regarding Kineret on our website portal. Make sure to send the patient’s prescriptions with the past health record.

2) Report submission of the Form

Complete the submission of Form No. 12A by attaching the patient’s prescription from a Registered Medical Practitioner (RMP).

3) Validation and cross-border importation

We check all the related documents and personal identification proofs to ensure the fulfillment of the eligibility criteria. And, when the permission from the Drugs Controller General (India) to import is obtained, our team makes the next move.

4) Vendor selection

Our professionals search for the global vendors and lock in your order at the best affordable value only after understanding their credibility.

5) Order fulfilment

All further processes, like transportation, transit, and doorstep delivery, are completely taken care of by our company staff.

Conclusion

Kineret availability often poses challenges; that’s where 24/7QualityMeds comes in. Our experienced team handles the complete process seamlessly. Get in touch with us, and we will handle the rest. Visit our website and explore more for updates.

by 24/7QualityMeds

November 12, 2025

Columvi is a drug used for cancer patients suffering from diffuse large B-cell lymphoma DLBCL), a cancer involving a kind of white blood cell. This DLBCL comes under the subtype called Non-Hodgkin’s Lymphoma (NHL). There are about 30-40% cases of NHL cases estimated worldwide. According to the GLOBOCAN 2022 data, there are approximately 1,50,000 to 2,20,000 new cases of DLBCL found every year among 5,45,000 new cases of NHL, affecting people globally.

Mechanism of action

Glofitamab is an active ingredient in Columvi, which is an antibody (a type of protein) manufactured in such a way to identify and bind to CD20, a type of protein that resides on the surface of healthy T cells (a type of white blood cell that takes part in the body’s natural defence and kills cancer cells). When the binding of both CD20 and CD3 occurs, the combination effects of both cancer cells and T-cells cause the cancer cells to die.

Indications

Columvi is a bispecific CD20-directed CD3 T-cell engager (unites the two types of immune cells, which are CD20 and CD3) is indicated for adults with relapse or refractory diffuse large B-cell lymphoma, not otherwise specified (DLBCL, NOS) or large B-cell lymphoma (LBCL) arising from follicular lymphoma after two or more after two or more lines of systemic therapy (therapy that affects the entire body).

Side effects

The most common side effects are listed below:

cytokine release syndrome (the body releases too many inflammation-causing chemicals)
musculoskeletal pain
Rash
Fatigue.

Other laboratory abnormalities include:

A decrease in lymphocyte count, phosphate, and neutrophil count, fibrinogen, and
An increase in uric acid.

Major Safety concerns and monitoring

Neurological Toxicity:

Some people may feel sleepy or have difficulty speaking or writing. Monitor the patient for long-term symptoms.

Infections:

Columvi can make the immune system weak. Monitor the patients for serious infections.

Tumor flare:

Monitor the patients for tumor flare after the cancer cells die.

Access Checklist:

The Glofitamab price in India varies from time to time since it is not registered in India, so we import Glofitamab from other countries through official legitimate channels at fair prices. We can help you buy Columvi in India when you get a prescription from certified doctors regarding your medical condition. We provide the medicine in the form of injection as 2.5mg/2.5mL or 10mg/10mL (1mg/1mL) in a single vial according to the dosage of the patient. Our specialised team guides you with the Glofitamab import process, as mentioned below:

Request for Columvi availability: We kindly request you to send a notification request for Columvi availability in India

Form no. 12: We assist in the submission of mandatory Form No. 12. Besides this requires submission of a proper prescription approved by a Registered Medical Practitioner (RMP).

Cross-checking of regulatory documents: We check all the prescriptions along with the patient’s medical documents to ensure eligibility for the legal Glofitamab import process.

Import the drugs: Importation is only possible after permission from higher authorities, such as the Drugs Controller General (India).

Navigating and delivery of the medicine: Our expert team navigates the location of Columvi availability with the suppliers who are internationally certified, checks their authenticity, and finalises it. We check the safe delivery of the medicine along with the warehouse section, shipment and finally till the door delivery of the medicine to the patient.

Conclusion

Do you want to make your journey through the import process of the rare medicines easy and transparent? 24/7QualityMeds takes utmost care of every step, be it documentation or delivery, without any confusion. We aim for your safety and satisfaction. Reach out to us today for your tailored medical needs.

by 24/7QualityMeds

November 10, 2025

Blincyto is a targeted immunotherapy approved worldwide to treat certain B-cell Acute Lymphoblastic Leukemia (ALL). The incidence of this disease is approximately 1-2 out of 1,00,000 persons. The adult patients suffering from ALL range from 7.3% to 57.8% whereas ALL in children accounts for 19% of childhood cancers in India by 2021.

Mechanism of action

Blincyto works by the concept of BiTE (Bispecific T-Cell Engager) therapy, in which CD19 surface antigens on B cells are targeted. This enables tracking and attacking the malignant cells by engaging T cells (a type of white blood cell that functions in destroying the cells considered enemies). When the T cells are brought in proximity to the cancer cells, these T cells release toxins and induce cancer cell death (apoptosis). Currently, the BiTE therapy is being investigated for its usage in different types of cancers to benefit patients on a larger scale.

Indications

Blincyto is indicated in the treatment of adults and children aged one month and older with:

CD19-positive B-cell precursor (immature B cell in bone marrow that shows the CD19 marker on its surface) Acute Lymphoblastic Leukaemia (ALL) in first or second complete recovery, along with Minimal Residual Disease (MRD), either greater than or equal to 0.1%.
CD19-positive B-cell precursor Acute Lymphoblastic Leukaemia (ALL) recurrence or refractory type.
CD19-positive B-cell Philadelphia chromosome-negative B-cell precursor Acute Lymphoblastic Leukaemia (ALL) in the consolidation phase of multiphase chemotherapy.

Side-effects

The most common side effects in patients taking Blincyto are high temperature, infusion-related reactions, headache, infection, musculoskeletal pain, low neutrophil count, low Red Blood Cell count, low thrombocyte count, and diarrhoea.

Warnings and precautions

Monitor the patients for infections
Monitor if the patient shows the symptoms of Pancreatitis
Follow the instructions as given by the manufacturer for preparation (including admixing) and administration
Avoid operating heavy or potentially dangerous machinery
Make sure to use preservative-free saline for children weighing less than 22 kg.

Ordering guide

Blincyto is available as an injection form of 35mcg in a single-dose vial. The blinatumomab availability in India is not authorized , but we help patients to import it in case of their critical need when the doctor advises the patient to buy blincyto India or to import it. We have simplified the ordering process in a step-by-step manner.

1) Order for a Blincyto medicine

You can request a Blincyto on the website and send all the medical history of the patient with a valid prescription for a diagnosed condition.

2) Submission of mandatory Form No. 12

Our team guides you in filing the Form No. 12. Submit a valid prescription from a Registered Medical Practitioner (RMD).

3) Confirmation of the documents

We confirm the documents by verifying the prescription given by a registered healthcare worker, and also the personal ID documents from the patient.

4) Blincyto import

Once the government authorities grant permission from the Drugs Controller General (India), we commence with the importation process.

5) Genuineness of the medicine

Our assigned team makes a note of all the worldwide suppliers and makes the best economic choice.

6) Packaging and distribution of the medicine

Our transport team ensures packaging, labeling, and quality and delivery of the product within the stipulated time.

The blinatumomab price in India is not constant, but we guarantee to provide the medicines at a cost-effective price meeting the international pharmaceutical norms, since it involves legal import channels.

Trust 24/7QualityMeds to access the medicines to patients in medical need with absolute transparency. Our dedicated team is here to manage everything, right from the import to delivery, so that you focus on what matters the most.

by 24/7QualityMeds

November 8, 2025

Vimzim is mainly composed of the most important substance known as Elosulfase Alfa. It is used to treat a rare genetic disorder known as mucopolysaccharidosis IV A (also called MPS IVA or Morquio A syndrome). According to the global record, ~1 in 150,000–250,000 births are affected with MPS IVA.

Mode of action

MPS IVA is due to the absence of an enzyme known as N-acetylgalactosamine-6-sulfatase, which plays a role in breaking down substances in the body called glycosaminoglycans (GAGs), which eventually build up in the bones and organs, causing short bones, difficulty in moving and breathing, clouding of the eyes and hearing loss. N-acetylgalactosamine-6-sulfatase in Elosulfase Alfa is the active substance present in Vimzim, which breaks down glycosaminoglycans (GAGs) in the body and stops the cells from building up randomly, resulting in reduced symptoms in patients suffering from MPS IVA.

Indications

Vimzim is indicated in patients suffering from mucopolysaccharidosis IV A (also called MPS IVA or Morquio A syndrome)

Side Effects

The common symptoms in patients taking this medicine are headache, nausea, vomiting, abdominal pain, diarrhoea, dizziness, chills, difficulty in breathing and oropharyngeal pain.

Import guidance

Elosulfase Alfa availability in India is not permitted as of the present date, but we can import into India only by the legal procedure, since it is not registered with the Central Drugs Standard Control Organisation (CDSCO) for domestic distribution.

Steps to Import Elosulfase Alfa

Send the Elosulfase Alfa request for an order on the website: To begin with, we kindly ask either the patients or their supporters to send all the therapeutic requirements, like prescriptions and the medical history of the patient since diagnosed with MPS IVA.
Form submission: Please submit the document under the Form No.12A for the permission from the Central Drugs Standard Control Organisation (CDSCO) to import Vimzim (Elosulfase Alfa) as required. Make sure to send a genuine prescription from a Registered Medical Practitioner (RMD).
Reviewing medical documents: We review all the submitted medical documents to make the import process smooth and to deliver the medicine to you for your personal medical use.
Permission to import: We start our import process for medicines when the medical sanctioning of the patient is approved by the government authorities.
Authorised Sourcing of the product: Our sourcing team coordinates with the best international marketers and finalises at the most favourable price.
Order Execution: Lastly, we take responsibility for all the shipments till the medicine reaches you.

Elosulfase Alfa Price in India

It is available in the brand name of BioMarin in the injection form as 5ml Vials. Since it is an enzyme replacement therapy, we set the Elosulfase alfa price in India according to the global standards. Also, its price keeps fluctuating depending on the weight and dosage of the patient, warehouses and government taxes.

Conclusion

If you are planning to buy Vimzim in India or check Vimzim availability, 24/7QualityMeds can provide support throughout the entire import procedure. We are committed to extending assistance in helping patients to import Elosulfase Alfa and other prescription medicines legally by maintaining transparency through all the steps. Contact us today to buy Vimzim in India, because we get the right medication at the right time.

by 24/7QualityMeds

November 7, 2025

Sacituzumab Govitecan is considered the main element in Trodelvy, which helps in treating adult patients with Triple-negative breast cancer. It is used to treat patients with advanced stages of Triple-negative breast cancer (TNBC). India estimates that 25-31% breast cancers are TNBC.

How does Trodelvy (Sacituzumab Govitecan) work?

Sacituzumab Govitecan is a combination of two active components.

Sacituzumab, which is a type of targeted therapy drug called a monoclonal antibody, and
SN-38, a chemotherapy drug.

Many breast cancer cells consist of a protein named ‘Trop-2’ on their surface. This protein transmits signals to breast cancer cells that promote progression. Sacituzumab is targeted to attach to Trop-2 and blocks it from transmitting the signals further. Now the SN-38 gets activated, which is aiming directly at breast cancer cells, eventually stopping cancer-causing cells from expanding. The impact of chemotherapy causes less harm to the healthy cells of your body by acting specifically on cancer cells.

Indications:

Unresectable locally advanced or metastatic triple-negative breast cancer (mTNBC) who have received two or more prior systemic therapies, at least one of them for metastatic disease (spreading to other parts of the body).
Unresectable locally advanced metastatic Hormone Receptor (HR)-positive, Human Epidermal growth factor Receptor (HER2)-negative (IHC0, IHC 1+ or IHC2+/ISH-breast cancer who received endocrine-based therapy (Hormone therapy) and at least two additional therapies in the metastatic setting.

Side effects:

The common side effects of Trodelvy are mentioned below:

Neutropenia (Low White blood cell count)
Severe Diarrhoea
Nausea
Vomiting
Hair loss
Allergic reactions
Fatigue
Light-headedness
Decreased appetite
Difficulty in breathing

Pricing and Availability:

The Sacituzumab Govitecan is not registered yet, as the Central Drug Standard Control Organisation (CDSCO) has not approved this medicine in India. So, the availability becomes limited, and patients can order only if it is prescribed by the doctor, after which we assist patients to buy Trodelvy in India through the legal way, right from the document verification to the final delivery of the product. The Sacituzumab Govitecan price in India may vary and depend on various factors like GST/local taxes, exchange rates, and changes in pricing policies of the company.

Safe Access:

Trodelvy is supplied in the form of one vial per box. Each single-dose vial consists of 180mg of Sacituzumab Govitecan (though some documentation shows 200mg fill as a manufacturing detail).

Steps to import process:

1) Request an order for Trodelvy : The patients or their family members can forward the prescription details and course of treatment.

2) Submission of a legal form (Form No.12) : We not only help in filing the Form No. 12A but also guide you in submitting it to the Drugs Controller General (India). Alongside this, a prescription from a Registered Medical Practitioner (RMP) is required.

3) Authentication of documents includes : Our team verifies the doctor’s prescription and all the required documents to ensure that the eligibility criteria for importing Trodelvy are according to legal guidelines.

4) Permission to import the medicine : We start the import process of the medicine as we get permission from the Drugs Controller General (India).

5) Authentic Product Sourcing : Our team connects with the authorised global suppliers and makes the best possible deal for the patient

6) Shipment and Delivery of the Medicine : We manage the logistics and coordinate with shipment procurement for safe and timely delivery of the medicine by all means.

Conclusion

If you are looking for any assistance to access sacituzumab govitecanin India? Connect with us at 24/7QualityMeds to get the sacituzumab govitecan price in India and also complete the process with ease according to legal ways and reliable sources.

by 24/7QualityMeds

November 6, 2025

Truqap or capivasertib is a serine/threonine kinase inhibitor. It inhibits the enzymatic activity of serine/threonine kinase isoforms AKT 1, 2, and 3, which play a role in proliferation of cancer cells with mutations in PIK3CA, AKT1 or PTEN genes. Thus, it aids in reducing the growth of cancer cells.

It is indicated, in combination with fulvestrant (anti-oestrogen medicine) for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer with one or more PIK3CA/AKT1/PTEN-mutations (as detected by an FDA-approved test) following progression on at least one endocrine-based regimen like aromatase inhibitor (to reduce estrogen levels) in the metastatic setting or recurrence on or within 12 months of completing adjuvant therapy.

Common adverse reactions to treatment with capivasertib include diarrhea, cutaneous adverse reactions, increased random glucose or hyperglycemia, decreased lymphocytes, decreased hemoglobin, increased fasting glucose, nausea, fatigue, decreased leukocytes, increased triglycerides, decreased neutrophils, increased creatinine, vomiting and stomatitis.

Capivasertib may cause fetal harm. Hence, it is advised to avoid use in pregnancy. Confirm negative pregnancy status before starting treatment. Use of effective contraception during treatment and for 4 months after the last dose, is advised.
Do not breastfeed during treatment due to potential for serious harm to infants. Not established as safe or effective for pediatric use. No efficacy differences in those ≥65 years, but higher rates of adverse reactions and treatment modifications. No dose changes needed for mild/moderate renal or hepatic impairment. Not studied in severe impairment. Monitor moderate hepatic cases closely.

Pricing and Availability

Capivasertib is not registered for commercial sale in India and is therefore unavailable through standard pharmacies or local distributors.
As this is a prescription-only therapy, pricing details for capivasertib are provided upon request, following the submission of valid medical documents and a doctor’s prescription. For the latest pricing information and procurement assistance, patients or caregivers are encouraged to contact our team directly.

The cost of capivasertib in India may vary depending on several factors, including supplier source, market conditions, regulatory requirements, and international availability. Additional elements such as shipping costs, documentation fees, origin country, and currency exchange rates may also influence the final price.

Fluctuations in GST or local taxes, as well as adjustments in manufacturer pricing policies, can further affect total cost. We facilitate patient access to capivasertib in India under the Named Patient Supply (NPS) program, ensuring full legal and regulatory compliance. Our dedicated support team oversees the process from document verification to final delivery, ensuring safety and transparency at each stage.

Access Pathway

Since capivasertib is not commercially licensed in India, it can only be accessed through the Named Patient Import Program (NPIP). Using this pathway, we assist patients in obtaining unregistered medicines like capivasertib under the NPIP framework, ensuring the process follows all applicable import regulations.

Through this program, we provide guidance on the necessary steps, documentation, and regulatory requirements, helping patients access the treatment they need safely and efficiently. Our support ensures that the import process is smooth while remaining fully compliant with Indian laws.

Capivasertib or Truqap is available as 64 film coated tablets in one bottle, where each tablet contains 60mg or 200mg.

Import Process

1) Submit Your Request
The patient or caregiver starts by sending a request that includes basic treatment details and a valid prescription.

2) Fill Form 12A
Next, Form 12A is completed and submitted along with a prescription from a Registered Medical Practitioner (RMP).

3) Document Review
All medical and ID documents are checked to make sure the patient is eligible to import the medicine for personal use.

4) Get Approval
Once the Drugs Controller General of India (DCGI) approves the request, the import process can move forward as per the prescription.

5) Source the Medicine
Our team works with trusted international suppliers to get the required medicine at the best possible price, ensuring it is authentic and compliant.

6) Delivery to Your Address
After final clearance, customs and logistics are handled to ensure the medicine is safely and quickly delivered to the patient’s address in India.

Required Documentation

To import capivasertib in India, patients must provide:

Valid prescription from a doctor, mentioning the medicine name, dosage, duration of treatment, and diagnosis.
Recent medical history and supporting lab reports, preferably issued within the last three months.
Government-issued ID and proof of residence of the patient.
Import permit, if required.

Orders are finalized only upon receipt of all required documents and verification of medical eligibility. Once the import permit is approved, the licensed supplier arranges shipment of capivasertib from approved international sources such as the United States, Canada, Europe, or Australia.

We ensure that every import is conducted safely, ethically, and in full regulatory compliance. Our organization provides nationwide delivery through verified suppliers, guaranteeing product authenticity and complete transparency in pricing and process. All prescriptions are reviewed and dispensed by registered pharmacists prior to delivery.

If you are looking for more detailed information about this medication, its availability, or guidance with the import procedure, our team is here to support you every step of the way. For personalised assistance, pricing details, and expert help in sourcing the medicine safely and legally, please visit 247qualitymeds.com. We are committed to helping patients access the treatment they need with confidence and ease.

by 24/7QualityMeds

November 5, 2025

Eculizumab is indicated for treatment of patients with paroxysmal nocturnal hemoglobinuria to reduce hemolysis, atypical hemolytic uremic syndrome to inhibit complement-mediated thrombotic microangiopathy, anti-AchR antibody-positive generalised myasthenia gravis, and anti-AQP4 antibody-positive neuromyelitis optica spectrum disorder. It is administered as an intravenous infusion. It is a recombinant humanised monoclonal IgG antibody (IgG2/4𝛋) produced by murine myeloma cell culture. It specifically binds to C5, a complement protein, inhibiting cleavage to C5a and C5b, which ultimately leads to C5b-9. It inhibits the intravascular hemolysis caused by the terminal product in patients with complement-mediated thrombotic microangiopathy in patients with aHUS. The precise mechanism in gMG and NMOSD is unknown, but it is presumed to involve inhibition of antibody-induced complement deposition.

There are certain risks in pregnant patients suffering from PNH and aHUS being administered Soliris. Published data does not report the presence of eculizumab in human milk, although maternal IgG may be present. No data on the effect on breastfed children or on milk production. Patients’ condition and potential effect on breastfed children need to be considered before deciding on treatment. Safety and effectiveness in pediatric patients have not been established – no apparent age-related differences in geriatric patients.

Soliris or eculizumab is contraindicated in patients with unresolved Neisseria meningitidis infection and those who are not currently vaccinated against the same infection, unless the risk of delaying the eculizumab treatment outweighs the risks of developing meningococcal infection. Adverse reactions of the treatment include serious meningococcal infections, infusion reactions as well as any other systemic infection. Specific adverse reactions include headache, nasopharyngitis, back pain, nausea, diarrhoea, urinary and respiratory tract infections, peripheral edema, abdominal pain, musculoskeletal pain, among others.

Pricing and Availability

Eculizumab is not registered in India and, therefore, not easily available through local pharmacies or standard supply channels.
As this is a prescription-only treatment, the price quotation for eculizumab is shared on request, after submission of valid medical documents. For the most current pricing and procurement details, patients or caregivers can contact us directly.

The cost of eculizumab in India may differ depending on market trends, supplier access, and regulatory developments, since the medicine is not approved for commercial distribution in the country. The overall price also varies based on supplier, country of origin, shipping costs, and documentation requirements.

Prices may further fluctuate due to GST/local taxes, currency exchange rates, and changes in manufacturer pricing policies. We assist patients to import eculizumab in India safely and lawfully, ensuring complete compliance with the Named Patient Supply (NPS) program. Our team supports patients through each step—from verifying documents to final delivery.

Access

As Eculizumab is not commercially approved in India, it can only be accessed through the Named Patient Import Program (NPIP). We support patients requiring medicines such as Eculizumab by helping procure them under the Named Patient Supply (NPS) route.

Eculizumab injection is available as one 300 mg/30 mL (10 mg/mL) single-dose vial per carton.

Import Process

Submit a request for your medicine
Patients or caregivers can share their prescription and treatment details to initiate the request.
Apply through Form 12A
An application in Form 12A must be submitted along with a valid prescription from a Registered Medical Practitioner (RMP).
Document verification
All medical documents and prescriptions are verified to confirm eligibility for importing the medicine in small quantities for personal medical use.
Import permission
Once approval is granted by the Drugs Controller General (India), the import procedure begins as per the prescription.
Sourcing the medicine
Our sourcing team coordinates with authorized international suppliers to find the best available price in India, ensuring product authenticity before finalizing the purchase.
Medicine delivery
After approval and confirmation, logistics are coordinated to ensure safe, compliant, and timely delivery to the patient’s address in India.

Required Documents

To enable the import of Eculizumab to India, patients must provide:

A valid prescription specifying the medicine name, dosage, treatment duration, and diagnosis.
Recent medical history and test reports (preferably from the last three months), including those confirming the diagnosis.
Government-issued ID and proof of residence of the patient.
Import permit (if applicable).

The order is confirmed only after receiving a valid prescription and the required documents. Once the import permit is approved, the licensed supplier arranges shipment of eculizumab from approved international sources such as the USA, Canada, Europe, or Australia.

Through this process, patients can import eculizumab into India safely and legally. We make the medicine available across major cities, sourcing only from genuine international suppliers to ensure quality and authenticity. We maintain complete transparency in pricing, and all prescriptions are reviewed by registered pharmacists before final dispatch.

Any patients seeking comprehensive information about this medication, including availability and guidance, are encouraged to reach out. For detailed support or pricing assistance, please visit 247qualitymeds.com.

by 24/7QualityMeds

November 4, 2025

Strensiq or asfotase alfa is indicated for the treatment of patients with perinatal/infantile- and juvenile-onset hypophosphatasia (HPP).

HPP is caused by a deficiency in TNSALP enzyme activity, leading to elevations in several substrates, like inorganic pyrophosphate (PPi). TNSALP is a metalloenzyme that catalyzes the hydrolysis of phosphomonoesters with the release of inorganic phosphate and alcohol. Elevated extracellular levels of PPi block hydroxyapatite crystal growth which inhibits bone mineralization and causes an accumulation of unmineralized bone matrix, which manifests as rickets and bone deformation in infants and children and as osteomalacia (softening of bones) once growth plates close, along with muscle weakness. Replacement of the TNSALP enzyme upon asfotase alfa treatment reduces the enzyme substrate levels.

There are no available data on asfotase alfa use in pregnant women to inform a drug-associated risk, presence of asfotase alfa in human milk, the effects on the breastfed infant, or the effects on milk production. Developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for asfotase alfa and any potential adverse effects on the breastfed infant from asfotase alfa or from the underlying maternal condition. Safety and effectiveness of asfotase alfa for the treatment of perinatal/infantile- and juvenile-onset HPP have been established in pediatric patients. There is no information available to determine whether geriatric patients differ in terms of adverse reactions and response, as compared to younger patients. Asfotase alfa is for subcutaneous injection only.

The following are the most adverse reactions reported in patients undergoing treatment (incidence rates being gretaer than 10%) with asfotase alfa: hypersensitivity reactions, lipodystrophy, ectopic calcifications, and possible immune-mediated clinical effects

Pricing and Availability

Asfotase alfa is not currently registered in India and is therefore not available through regular pharmacies or standard distribution channels.
As this is a prescription-only medication, a price quotation for asfotase alfa is shared only after reviewing valid medical documents and a doctor’s prescription. For the most up-to-date pricing and supply details, patients may contact our support team.

The price of asfotase alfa in India may differ based on factors such as market demand, supplier access, import regulations, and availability from international manufacturers. The total cost may also depend on shipping charges, origin country, documentation fees, and currency exchange rates.

Pricing may be affected by local taxes (GST) and any revisions in company or distributor pricing policies.
We assist patients in India with the safe and lawful access through import asfotase alfa through the Named Patient Supply (NPS) program, ensuring compliance with all import regulations. Our services include document verification, import coordination, and doorstep delivery of the medicine.

Patient Access

Since asfotase alfa is not approved for commercial sale in India, it can be obtained only through the Named Patient Import Program (NPIP).
We help patients obtain unregistered medicines under the NPS route, maintaining full adherence to applicable legal and regulatory standards.

Strensiq or asfotase alfa is available as injection: 18 mg/0.45 mL, 28 mg/0.7 mL, 40 mg/mL, or 80 mg/0.8 mL solution in single-dose vials with each carton containing 1 or 12 vials.

Import Procedure

Medicine Request Submission: Patients or caregivers can begin by submitting a request, along with their doctor’s prescription and treatment information.
Filing Form 12A: A completed Form 12A and a valid prescription from a Registered Medical Practitioner (RMP) must be submitted.
Verification Process: All documents are carefully reviewed to confirm the patient’s eligibility to import the medicine for personal medical use.
Regulatory Approval: Once approval is received from the Drugs Controller General (India), the import procedure is initiated in accordance with the approved prescription.
Medicine Procurement: Our procurement specialists connect with licensed international suppliers to source the medicine at the best possible rate while ensuring authenticity and quality.
Product Delivery: Following approval and shipment, logistics are handled to ensure timely, safe, and compliant delivery of the medicine to the patient’s address in India.

Documents Required

To import asfotase alfa into India, patients must provide the following:

A valid prescription indicating the medicine name, dosage, duration, and diagnosis.
Recent medical history and diagnostic reports (preferably from the last three months).
Government-issued ID proof and proof of residence.
Import permit (if required).

Orders are confirmed only after the submission and verification of all necessary documents. Once the import authorization is granted, shipment of asfotase alfa is arranged by a licensed global supplier typically from the USA, Canada, Europe, or Australia.

This process ensures that patients in India can legally and securely access and buy asfotase alfa in India. We coordinate with reliable international sources, maintain pricing transparency, and ensure all deliveries are pharmacist-verified and fully compliant with import regulations.

For the best pricing, authentic sourcing, and priority assistance, connect with 247QualityMeds.com today. Our team ensures a safe and easy buying process.

by 24/7QualityMeds

November 3, 2025

Mirvetuximab soravtansine-gynx for the treatment of adult patients with FRα–positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer who have received 1-3 prior systemic treatment regimens. Patients are selected for therapy based on an FDA-approved test.

Mirvetuximab soravtansine-gynx is an antibody-drug conjugate (ADC) where the monoclonal antibody is a chimeric IgG1 that targets folate receptor alpha (FRα). Th antibody is linked to a small molecule, DM4 (also known as soravtansine or ravtansine), a microtubule inhibitor by a cleavable linker. Upon binding to FRα, mirvetuximab soravtansine-gynx is internalized followed by intracellular release of DM4 via proteolytic cleavage. DM4 disrupts the microtubule network within the cell, resulting in cell cycle arrest and apoptotic cell death, and diffuse to nearby cells causing further cell death. FRα is a receptor that is overexpressen on the surface epithelial tumor cells, characteristic of ovarian, endometrial, triple-negative breast and non-small-cell lung cancers.

The most common adverse reactions include vision impairment, pneumonitis, fatigue, increased aspartate aminotransferase, nausea, increased alanine aminotransferase, keratopathy, abdominal pain, decreased lymphocytes, peripheral neuropathy, diarrhea, decreased albumin, constipation, increased alkaline phosphatase, dry eye, decreased magnesium, decreased leukocytes, decreased neutrophils, and decreased hemoglobin.

The cytotoxic and gentoxic component DM4 can be toxic to actively dividing cells, suggesting its potential to cause embryotoxicity and teratogenicity. Advise patients of potential risk to fetus.

Because of the potential for serious adverse reactions in a breastfed child, advise women not to breastfeed during treatment and for 1 month after the last dose.

Advise females to use effective contraception during treatment and for 7 months after the last dose.

Safety and effectiveness of mirvetuximab have not been established in pediatric patients.

No clinically meaningful differences in efficacy or safety were observed in geriatric patients compared to younger patients. No dosage adjustment of mirvetuximab is recommended for patients with mild to moderate renal or mild hepatic impairment. The effect of severe renal impairment or end-stage renal disease on mirvetuximab is unknown. Avoid use of mirvetuximab in patients with moderate or severe hepatic impairment.

Pricing and Availability

Mirvetuximab Soravtansine (Elahere) is not registered in India and, therefore, not easily available through local pharmacies or standard supply channels.
As this is a prescription-only treatment, the price quotation for mirvetuximab is shared on request, after submission of valid medical documents. For the most current pricing and procurement details, patients or caregivers can contact us directly.

The cost of mirvetuximab in India may differ depending on market trends, supplier access, and regulatory developments, since the medicine is not approved for commercial distribution in the country. The overall price also varies based on supplier, country of origin, shipping costs, and documentation requirements.

Prices may further fluctuate due to GST/local taxes, currency exchange rates, and changes in manufacturer pricing policies. We assist patients in importing mirvetuximab in India safely and lawfully, ensuring complete compliance with the Named Patient Supply (NPS) program. Our team supports patients through each step-from verifying documents to final delivery.

Access

As mirvetuximab is not commercially approved in India, it can only be accessed through the Named Patient Import Program (NPIP). We support patients requiring medicines by helping procure them under the Named Patient Supply (NPS) route.

Each mirvetuximab soravtansine-gynx injection carton contains one single-dose vial containing 100 mg of mirvetuximab soravtansine-gynx in 20 mL (5 mg/mL) of clear to slightly opalescent, colorless sterile solution.

Import Process

Submit a request for your medicine
Patients or caregivers can share their prescription and treatment details to initiate the request.
Apply through Form 12A
An application in Form 12A must be submitted along with a valid prescription from a Registered Medical Practitioner (RMP).
Document verification
All medical documents and prescriptions are verified to confirm eligibility for importing the medicine in small quantities for personal medical use.
Import permission
Once approval is granted by the Drugs Controller General (India), the import procedure begins as per the prescription.
Sourcing the medicine
Our sourcing team coordinates with authorized international suppliers to find the best available price of mirvetuximab soravtansine in India, ensuring product authenticity before finalizing the purchase.
Medicine delivery
After approval and confirmation, logistics are coordinated to ensure safe, compliant, and timely delivery to the patient’s address in India.

Required Documents

To enable the import of mirvetuximab to India, patients must provide:

A valid prescription specifying the medicine name, dosage, treatment duration, and diagnosis.
Recent medical history and test reports (preferably from the last three months), including those confirming the diagnosis.
Government-issued ID and proof of residence of the patient.
Import permit (if applicable).

The order is confirmed only after receiving a valid prescription and the required documents. Once the import permit is approved, the licensed supplier arranges shipment of mirvetuximab from approved international sources such as the USA, Canada, Europe, or Australia.

Through this process, patients can import mirvetuximab into India safely and legally. We make the medicine available across major cities, sourcing only from genuine international suppliers to ensure quality and authenticity. We maintain complete transparency in pricing, and all prescriptions are reviewed by registered pharmacists before final dispatch. For pricing details or to request assistance in accessing mirvetuximab, visit 24/7QualityMeds.com.

Older Posts